Phyllis Gotlib Sells 3,706 Shares of American Well (NYSE:AMWL) Stock

American Well Corporation (NYSE:AMWL) insider Phyllis Gotlib sold 3,706 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $5.30, for a total value of $19,641.80. Following the completion of the transaction, the insider directly owned 163,004 shares in the company, valued at approximately $863,921.20. This represents a 2.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Phyllis Gotlib also recently made the following trade(s):

• On Friday, January 2nd, Phyllis Gotlib sold 3,707 shares of American Well stock. The shares were sold at an average price of $4.85, for a total transaction of $17,978.95.

American Well Stock Performance

Shares of American Well stock traded up $0.22 on Thursday, hitting $5.51. 22,215 shares of the company traded hands, compared to its average volume of 92,324. The stock has a market capitalization of $91.12 million, a P/E ratio of -0.93 and a beta of 1.34. American Well Corporation has a 52 week low of $3.71 and a 52 week high of $9.15. The business has a 50-day simple moving average of $5.20 and a 200 day simple moving average of $5.09.

American Well (NYSE:AMWL) last issued its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.59) by $0.07. American Well had a negative return on equity of 35.33% and a negative net margin of 38.38%.The firm had revenue of $55.31 million during the quarter, compared to analyst estimates of $52.71 million. Research analysts expect that American Well Corporation will post -9.34 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AMWL. Wall Street Zen upgraded American Well from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. Stifel Nicolaus lowered their target price on American Well from $6.00 to $5.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Weiss Ratings reissued a “sell (e+)” rating on shares of American Well in a report on Wednesday, January 21st. Finally, Morgan Stanley reduced their price target on shares of American Well from $10.50 to $6.00 and set an “equal weight” rating on the stock in a research report on Thursday, December 18th. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $7.42.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Rock Point Advisors LLC lifted its holdings in shares of American Well by 49.3% in the 3rd quarter. Rock Point Advisors LLC now owns 259,171 shares of the company’s stock worth $1,594,000 after acquiring an additional 85,581 shares during the last quarter. Monaco Asset Management SAM bought a new position in American Well during the 4th quarter valued at about $338,000. Squarepoint Ops LLC raised its position in American Well by 74.5% in the 4th quarter. Squarepoint Ops LLC now owns 115,061 shares of the company’s stock worth $565,000 after purchasing an additional 49,135 shares during the period. Goldman Sachs Group Inc. raised its position in American Well by 280.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company’s stock worth $510,000 after purchasing an additional 47,745 shares during the period. Finally, Jane Street Group LLC lifted its stake in American Well by 232.9% in the first quarter. Jane Street Group LLC now owns 64,112 shares of the company’s stock worth $505,000 after purchasing an additional 44,852 shares during the last quarter. Institutional investors own 56.05% of the company’s stock.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.